All news

A director's trust sells 10,000 shares under a trading plan at Corcept Therapeutics (CORT).

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

James N. Wilson, a director at Corcept Therapeutics Inc. (CORT), reported that his trust sold a total of 10,000 common shares on October 15, 2026, under a Rule 10b5-1 trading plan established on March 12, 2026. The shares were sold in three transactions at weighted average prices ranging from

Read original source

CORT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.